Advertisement

PARK2 and PARK7 Gene Polymorphisms as Risk Factors Associated with Serum Element Concentrations and Clinical Symptoms of Parkinson’s Disease

  • Jaya Sanyal
  • Athira Anirudhan
  • Tapas Kumar Banerjee
  • Gautam Guha
  • Ramakrishnan Veerabathiran
  • Ram Murugesan
  • S. S. J. Shiek AhmedEmail author
  • Vadlamudi Raghavendra RaoEmail author
Original Research

Abstract

Besides clinical and imaging techniques, there is a lack of molecular makers for the diagnosis of Parkinson’s disease (PD). There is an immense need to develop biomarkers associated with the phenotypes which may be valuable for individualized treatment. Single-nucleotide polymorphisms (PARK2: Ser167Asn (G>A) and Val380Leu (G>C); PARK7: IVS4 + 46G>A and IVS4 + 30T>G) in PD-related genes were examined to elucidate its relationship with concentration of serum elements and clinical symptoms of PD. A total of 214 PD patients and 213 controls from Indian population were genotyped using PCR and DNA sequencing methods. The serum element concentrations were detected and clinical symptoms were determined based on UPDRS scale and recorded at the time of sample collection. The IVS4 + 30T>G, Ser167Asn (G>A) and Val380Leu (G>C) polymorphisms appeared to alter element concentrations in PD. The patients with Ser167Asn polymorphism showed significant association with copper, iron and zinc that reinforces the role of A allele as a factor for change in the concentrations of elements, than those patients with G allele. In particular, patients with A allele of Ser167Asn have risk of having high serum iron concentration (OR 11.55, 95% CI 5.59–23.85), which are associated with dementia and postural imbalance. Similar results were observed for Val380Leu (G>C) and IVS4 + 30T>G polymorphisms which suggest their role in element concentration and neurological symptoms. Overall, our study demonstrates the influence of polymorphisms of PD genes on element concentrations and clinical symptoms. Results of this study may be taken into account when considering the contributing factors for PD symptoms.

Keywords

Serum trace element Metal imbalance Parkinson’s disease Gene polymorphisms 

Notes

Acknowledgements

This research work is supported by the Grant (Project Sanction No: 4-FP/6/PMI (Considered under National project “Human Origins, Genome and People of India-DNA Polymorphism”)) from Anthropological Survey of India, Ministry of Culture, Government of India and ICMR EMS Grant to VRR (Letter No. 74/1/2016-Pers.EMS). We are thankful to the team of doctors, the PD patients and control subjects for voluntarily taking part in this research work and donating their blood samples. We also thank Mitali Maity (nurse in NNC) for helping in the collection of blood samples from the OPD of NNC. JS is thankful to CSIR for providing the Research Associate Fellowship (CSIR RA Code ID: 9/45(1283)/2013 EMR-I).

Author Contributions

JS designed the research work with VRR and SSSJA, performed the experiments and wrote the manuscript. SSSJA planned the research work, statistically analysed the data and wrote the draft of the manuscript. AA was involved in the statistical analysis. R provided critical suggestion for the genetic analysis. RM provided critical suggestion while analysing the data. TKB and GG are the clinical collaborators involved in identifying the PD patients and control. VRR organized the research project, mentor, who received the grant for the project on PD in India.

Funding

This research work is supported by the Grant (Project Sanction No: 4-FP/6/PMI (Considered under National project “Human Origins, Genome and People of India-DNA Polymorphism”)) from Anthropological Survey of India, Ministry of Culture, Government of India and ICMR EMS grant to VRR (Letter No 74/1/2016-Pers.EMS).

Compliance with Ethical Standards

Conflict of interest

The authors declare no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Supplementary material

10571_2019_734_MOESM1_ESM.docx (23 kb)
Supplementary material 1 (DOCX 22 kb)

References

  1. Ahmed SSSJ, Santosh W (2010) Metallomic profiling and linkage map analysis of early Parkinson’s disease: a new insight to aluminum marker for the possible diagnosis. PLoS ONE 5:e11252CrossRefGoogle Scholar
  2. Alexander GE (2004) Biology of Parkinson’s disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder. Dialogues Clin Neurosci 6:259–280Google Scholar
  3. Bertoli-Avella AM, Oostra BA, Heutink P (2004) Chasing genes in Alzheimer’s and Parkinson’s disease. Hum Genet 114:413–438CrossRefGoogle Scholar
  4. Björkblom B, Adilbayeva A et al (2013) Parkinson disease protein DJ-1 binds metals and protects against metal-induced cytotoxicity. J Biol Chem 2 288(31):22809–22820CrossRefGoogle Scholar
  5. Bocca B, Forte G, Petrucci F, Senofonte O et al (2005) Development of methods for the quantification of essential and toxic elements in human biomonitoring. Ann Ist Super Sanita 41:165–170Google Scholar
  6. Bocca B, Alimonti A, Senofonte O, Pino A et al (2006) Metal changes in CSF and peripheral compartments of parkinsonian patients. J Neurol Sci 248:23–30CrossRefGoogle Scholar
  7. Bonifati V, Rizzu P, van Baren MJ et al (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299:256–259CrossRefGoogle Scholar
  8. Caudle WM, Guillot TS (2012) Industrial toxicants and Parkinson’s disease. Neurotoxicology 33:178–188CrossRefGoogle Scholar
  9. Chakraborty S, Chen P et al (2015) Loss of pdr-1/parkin influences Mn homeostasis through altered ferroportin expression in C. elegans. Metallomics 7(5):847–856CrossRefGoogle Scholar
  10. Cordato DJ, Chan DK (2004) Genetics and Parkinson’s disease. J Clin Neurosci 11:119–123CrossRefGoogle Scholar
  11. Forte G, Bocca B, Senofonte O, Petrucci F et al (2004) Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson’s disease. J Neural Transm 111:1031–1040CrossRefGoogle Scholar
  12. Forte G, Alimonti A, Pino A, Stanzione P et al (2005) Metals and oxidative stress in patients with Parkinson’s disease. Ann Ist Super Sanita 41:189–195Google Scholar
  13. Ikawa M, Okazawa H, Kudo T, Kuriyama M et al (2011) Evaluation of striatal oxidative stress in patients with Parkinson’s disease using [62Cu] ATSM PET. Nucl Med Biol 38:945–951CrossRefGoogle Scholar
  14. Jenner P, Olanow W (2006) The pathogenesis of cell death in Parkinson’s disease. Neurology 66:S24–S36CrossRefGoogle Scholar
  15. Koç ER, Ilhan A, AytüRk Z, Acar B et al (2015) A comparison of hair and serum trace elements in patients with Alzheimer disease and healthy participants. Turkish J Med Sci 45:1034–1039CrossRefGoogle Scholar
  16. Lavanya PD, Reddy BS, Rao DA et al (2014) Trace elemental analysis of blood serum samples of patients afflicted with Parkinson’s disease. Int J Bioassays 3:1858–1865Google Scholar
  17. Meamar R, Chitsaz A, Aghaye-Ghazvini MR (2015) Trace blood elements and severity of Parkinson’s disease. J Res Med Sci 32:1870–1878Google Scholar
  18. Medeiros MS, Schumacher-Schuh A, Cardoso AM et al (2016) Iron and oxidative stress in Parkinson’s disease: an observational study of injury biomarkers. PLoS ONE 11:e0146129CrossRefGoogle Scholar
  19. Moore DJ, Zhang L, Troncoso J, Lee MK et al (2005) Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. Hum Mol Genet 14:71–84CrossRefGoogle Scholar
  20. Morett E, Bork P (1999) A novel transactivation domain in Parkin. Trends Biochem Sci 24:229–331CrossRefGoogle Scholar
  21. Muralidhar LH et al (2004) Serum trace element levels and the complexity of inter-element relations in patients with Parkinson’s disease. J Trace Elem Med Biol 18:163–171CrossRefGoogle Scholar
  22. Nikam S, Nikam P, Ahaley SK, Sontakke AV (2009) Oxidative stress in Parkinson’s disease. Indian J Clin Biochem 24:98–101CrossRefGoogle Scholar
  23. Ogunrin AO, Komolafe MA, Sanya EO et al (2013) Trace metals in patients with Parkinson’s disease: a multi-centre case–control study of Nigerian patients. J Neurol 1:31–38Google Scholar
  24. Pekny M, Pekna M, Messing A, Steinhäuser C et al (2016) Astrocytes: a central element in neurological diseases. Acta Neuropathol 131(3):323–345CrossRefGoogle Scholar
  25. Sanyal J, Jana A, Ghosh E, Banerjee TK et al (2015) Evaluation of PARKIN gene variants in West Bengal Parkinson’s disease patients. J Hum Genet 60:485–492CrossRefGoogle Scholar
  26. Sanyal J, Ahmed SSSJ, Tony Ng HK, Naiya T (2016) Metallomic biomarkers in cerebrospinal fluid and serum in patients with Parkinson’s disease in Indian population. Sci Rep 6:35097CrossRefGoogle Scholar
  27. Sensi SL, Granzotto A, Siotto M, Squitti R (2018) Copper and zinc dysregulation in Alzheimer’s disease. Trends Pharmacol Sci 39(12):1049–1063CrossRefGoogle Scholar
  28. Zhang Y, Wang ZZ, Sun HM (2012) Lack of association between p.Ser167Asn variant of Parkin and Parkinson’s disease, a meta-analysis of 15 studies involving 2280 cases and 2459 controls. Am J Med Genet 15:38–47CrossRefGoogle Scholar
  29. Zhao H-W, Lin J, Wang X-B et al (2013) Assessing plasma levels of selenium, copper, iron and zinc in patients of Parkinson’s disease. PLoS ONE 8:e83060CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Jaya Sanyal
    • 1
  • Athira Anirudhan
    • 2
  • Tapas Kumar Banerjee
    • 3
  • Gautam Guha
    • 4
  • Ramakrishnan Veerabathiran
    • 5
  • Ram Murugesan
    • 2
  • S. S. J. Shiek Ahmed
    • 2
    Email author
  • Vadlamudi Raghavendra Rao
    • 6
    • 7
    Email author
  1. 1.Department of AnthropologyUniversity of DelhiDelhiIndia
  2. 2.Drug Discovery Lab, Faculty of Allied Health SciencesChettinad Academy of Research and EducationTamil NaduIndia
  3. 3.Department of NeurologyNational Neurosciences CentreKolkataIndia
  4. 4.Department of NeurologyNil Ratan Sircar Medical College and HospitalKolkataIndia
  5. 5.Genetics Lab, Faculty of Allied Health SciencesChettinad Academy of Research and EducationTamil NaduIndia
  6. 6.Department of GeneticsOsmania UniversityHyderabadIndia
  7. 7.Genome FoundationHyderabadIndia

Personalised recommendations